IMMUNOABLATIVE THERAPIEN

Patent europeic · EP3632446 · En vigur

Inscripziun en il register

Numer da publicaziun
EP3632446
Numer da la dumonda
EP19201254
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Limità
Annunzià
03-10-2019
Publitgà
08-04-2020
Concedì
13-01-2021
La protecziun finescha il pli tard
02-10-2039
Proxima taxa annuala scadenta
31-10-2026
Classas IPC
A61K 31/573 (2006.01)
A61P 37/06 (2006.01)
Prioritad
EP 18198491 03.10.2018
US 201816227068 20.12.2018
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-11-2025

    Midada

    Published in Swissreg on 01.11.2025

  2. 01-11-2024

    Midada

    Published in Swissreg on 01.11.2024

  3. 29-04-2024

    Midada

    Published in Swissreg on 29.04.2024

  4. 27-12-2023

    Midada

    Published in Swissreg on 27.12.2023

  5. 07-03-2023

    Midada

    Published in Swissreg on 07.03.2023

  6. 01-11-2022

    Midada

    Published in Swissreg on 01.11.2022

  7. 24-11-2021

    Midada

    Published in Swissreg on 24.11.2021

  8. 13-01-2021

    Concedì

    Published in Swissreg on 13.01.2021

Partidas

Possessur

AVM Biotechnology, LLC

1749 Dexter Ave North, Seattle, WA 98109, US

Inventur

Deisher, Theresa

Seattle, WA Washington 98109, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.